(S)-BINAP, min.98%, 1 g, emballage en verre

N-(4-Formylphenyl)methanesulfonamide, 95.0%, 5g

1-(2-(Trifluoromethyl)phenyl)cyclopropanecarboxylic acid, 95.0%, 1g

5-Acetyl-2-amino-4-hydroxybenzoic acid, 95.0%, 100mg

4-(2,6-di-tert-butyl-4-((2-((3,5-di-tert-butyl-4-hydroxyphenyl)thio)propan-2-yl)thio)phenoxy)-4-oxobutanoic acid, 98%, 100mg

Methyl 3-Oxohexanoate>96.0%(GC)500mL

1-BROMO-4-(3-BROMOPROPYL)BENZENE, 95.0%, 10g

1,2-BENZISOTHIAZOL-3(2H)-ONE, 5-METHOXY-, 1,1-DIOXIDE, 95.0%, 250mg

3-Bromo-4-chloroquinoline, 95.0%, 1g

tert-Butyl 3-(4-nitrophenyl)azetidine-1-carboxylate, 97%, 5g

6-Bromo-3-ethyl-2-methoxyquinoline, 95.0%, 1g

3,6-Dibromo-9-[4-(2-ethylhexyloxy)phenyl]-9H-carbazole, 98%, 100mg

N-Fmoc-N'-methyl-L-asparagine, 97.0%, 100mg